NH TherAguix announces FDA acceptance of IND to initiate clinical trials in the USA

,
Meylan - November 16th, 2020 NH TherAguix (“NHT”) today announces that the U.S. Food and Drug Administration ("FDA") has accepted the company's Investigational New Drug Application ("IND") for its drug candidate AGuIX to be combined with…